Clin2
NCT06508671Possibly a fitNot yet recruiting

Study of a drug for memory problems after chemotherapy

Chemotherapy-Related Cognitive ImpairmentDL-3-n-butylphthalide

Part of Mental health clinical trials.

This study tests a drug called butylphthalide to see if it can help with memory and thinking problems that some people have after finishing chemotherapy. If you have had certain types of chemo and are struggling with your memory, this might be a way to find help.

Summary written for real people, not researchers, by Clin2.

Phase
Phase 4
Enrollment
100 people
Ages
35 years to 80 years
Study type
Interventional

Who can take part

  • You have had chemotherapy with drugs like paclitaxel, docetaxel, or cisplatin (alone, not combined with other chemo drugs).
  • You are between 35 and 80 years old.
  • You have had memory or thinking problems for at least 3 months.
  • You have finished your cancer treatment and are considered cured (except for hormone therapy).
  • You can read and understand Chinese, and can complete questionnaires on your own or with help.
  • You have no other serious health conditions like heart disease, stroke, or epilepsy, and are not taking medications that affect memory.

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT05976152Recruiting· Phase 3
Butyphthalide to improve thinking after a recent stroke

This Phase 3 study tests whether butyphthalide can help thinking and memory improve after an acute ischemic stroke. It compares people who take the study medicine versus usual care, and measures cognitive (thinking) changes over follow-up.

Dandong, Liaoning
NCT07193277Recruiting· Phase 4
Butylphthalide for thinking problems in older adults with epilepsy

This study tests whether a medicine called butylphthalide can help improve memory and thinking in older adults with focal epilepsy who already have mild cognitive issues. It aims to find a new way to support brain health in people with epilepsy.

Wenzhou, Zhejiang
NCT07454473Recruiting· Phase 4
Edaravone and Dexborneol for chemo-related memory loss

This trial tests if a sublingual tablet can help people who have memory and thinking problems related to chemotherapy. If you have had certain types of chemotherapy and now notice trouble with your memory or concentration, this treatment might help improve your symptoms.

Shenyang, Liaoning
NCT02290834Recruiting
Studying brain and thinking changes after chemotherapy in older breast cancer patients

This study looks at how chemotherapy may affect memory and thinking, using thinking tests and possibly brain imaging. It compares older breast cancer patients who do and do not get chemotherapy, plus a group of healthy older adults.

Boston, Massachusetts
NCT06662474Not yet recruiting
Improving thinking and memory in breast cancer survivors

This study looks at memory, focus, and other thinking skills in women who finished breast cancer treatment. It aims to find ways to help with any mental difficulties after treatment.

NCT05305092Recruiting
Study of memory and thinking in early breast cancer

This study checks how breast cancer affects memory and thinking before other treatments start. It may help doctors better understand cognitive changes and who is most at risk.

Xi'an, Shaanxi

Hear when a new Chemotherapy-Related Cognitive Impairment trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.